Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Sutro Biopharma, Inc. (NASDAQ:STRO) Stock Rated "Buy" by Wall Street Brokerages

Summary by MarketBeat
Sutro Biopharma, Inc. (NASDAQ:STRO - Get Free Report) has earned a consensus recommendation of "Buy" from the thirteen ratings firms that are presently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, ten have assigned a buy re

1 Articles

MarketBeatMarketBeat
Center

Sutro Biopharma, Inc. (NASDAQ:STRO) Stock Rated "Buy" by Wall Street Brokerages

Sutro Biopharma, Inc. (NASDAQ:STRO - Get Free Report) has earned a consensus recommendation of "Buy" from the thirteen ratings firms that are presently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, ten have assigned a buy re

·Sioux Falls, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

MarketBeat broke the news in Sioux Falls, United States on Sunday, October 4, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

San Mateo, California icon

San Mateo, California

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal